ENTX Insider Trading Activity and SEC Form 4 Filings
ENTX insider trading summary
Over the past 12 months, insiders at Entera Bio Ltd. (ENTX) reported 4 open-market purchases worth $76K by 3 insiders and no sales on SEC Form 4. Net insider buying was $76K.
Latest ENTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 5, 2026 | Sean Ellis | Director | Buy | $12K (10,000 @ $1.23) |
| Feb 10, 2026 | Geno J Germano | Director | Buy | $30K (20,000 @ $1.49) |
| Feb 10, 2026 | Haya Taitel | Director | Buy | $11K (7,500 @ $1.48) |
| Feb 9, 2026 | Sean Ellis | Director | Buy | $22K (18,000 @ $1.24) |
| Jan 12, 2024 | Haya Taitel | Director | Buy | $9K (9,500 @ $0.99) |
| Jan 10, 2024 | Haya Taitel | Director | Buy | $6K (7,615 @ $0.77) |
| Dec 22, 2023 | Gerald M Lieberman | Director | Buy | $17K (23,952 @ $0.71) |
| Dec 22, 2023 | Miranda Jayne Toledano | Chief Executive Officer | Buy | $17K (23,952 @ $0.71) |
| Aug 22, 2023 | Haya Taitel | Director | Buy | $11K (18,000 @ $0.62) |
| Aug 21, 2023 | Gerald M Lieberman | Director | Buy | $12K (20,000 @ $0.59) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.